Page 292 - DOENÇA MENINGOCÓCICA - VOLUME 2 - DIGITAL
P. 292

195)  VASCONCELOS,  R.  F.;  MELLES,  C.  E.  A.;  ULSON,  C.  M.;  HUTZLER,  R.  U.;
                KIRCHNER, E.; STAPE, D. D. B. & RODRIGUES, E. Portadores de meningococos entre
                funcionários de Hospital Universitário. Rev. Hosp. Clín. Fac. Med. Univ. São Paulo, São
                Paulo, 32: 328-334, 1977.

                196) WAHDAN, M. A.; SALLAM, S. A.; HASSAN, M. M.; GAWAD, A. A.; RAKHA, A. S.; SIPPEL,
                J. E.; HABLAS, R.; SANBORN, W. R.; KASSEM, N. M.; RIAD, S. M.; &CVEJETANOVIC, B.
                A second controlled field trial of a serogroups A meningococcal polysaccharide vaccine in
                Alexandria. Bull. WHO., Geneva, 55: 645-651, 1977.

                197) BRANDT, L. B.; SMITH, C. D. & ARTENSTEIN, M. S. Immunogenicity of serogroup
                A and C Neisseria meningitidis polysaccharide vaccines administered together in humans.
                J. Infect. Dis., Chicago, 137: 202-205, 1978.

                198) DAVIS, C. E.; ZIEGLER, E. J. & ARNOLD, K. F. Neutralization of meningococcal
                endotoxin by antibody to core glycolipide. J. Exp. Med., Cambridge, 147: 1007-1017, 1978.

                199) FALLON, R. J. Virulence of meningococci. Lancet., London, 2: 674, 1978. (letter).

                200) FARQUHAR, J. D.; HANKINS, W. A.; DESANCTIS, A. N. DEMEIO, J. L. & METZGAR,
                D. P. Clinical and serological evaluation of a meningococcal polysaccharide vaccine groups
                A and Y (39995). Proc. Soc. Ex. Biol. Med. New York, 157: 79-82, 1978.

                201) GOLD, R.; GODSCHNEIDER, I.; LEPOW, M. L.; DRAPER, T. F. & RANDOLPH, M.
                Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children.  J.
                Infect. Dis., Chicago, 137: 112-121, 1978,

                202) GOTSCHLICH, E. C.; AUSTRIAN, R.; CVJETANOVIC, B. & ROBBINS, J. B. Prospects
                for the prevention of bacterial meningitis with polysaccharide vaccines.  Bull. WHO.,
                Geneva, 56: 509-517, 1978.

                203)  GREENWOOD, B.  M.;  HASSAN-KING,  M. &  WHITTLE,  H. C.  Prevention  of
                secondary cases of meningococcal disease in household contacts by vaccination. Br. Med.
                J. London, 1: 1317-1319, 1978.
                204) HOFF, G. E. & HOIBY, N. Cross-reactions between Neisseria meningitidis and twenty-
                seven other bacterial species. Acta Pathol Microbiol. Scand. (B), Copenhagen: 86: 87-92,
                1978.
                205) LAPEYSSONIE, L. De nouveau visage de laméningite a meningocoques. Med. Trop.,
                Marseille, 38: 9-12, 1978.

                206) MAKELA,  P. A. & PELTOLA,  H.; Group-specific meningococcal  vaccination  and
                epidemics caused by other groups of meningococci. Lancet, London, 2: 780-781, 1978.
                (letter).

                207) MARZOCHI, M. C. A.; TURINI, T. L. à VASCONCELOS, L. M. & MARZOCHI, K. B. F.
                Distribuição dos sorogrupos A e C da N. meningitidis no Município de Londrina, Paraná.
                João Pessoa, 1978. Trabalho apresentado no XIV Congresso Brasileiro da Sociedade
                Brasileira de Medicina Tropical (mimeo).


                                                        290
   287   288   289   290   291   292   293   294   295   296   297